Syndecan-1 overexpression promotes tumor growth and angiogenesis in an endometrial cancer xenograft model

International Journal of Gynecological Cancer

Volumn 20, Issue 5, 2010, Pages 751-756

  Oh, Jeong Hyun ^a   Lee, Hae Sun ^b   Park, Sang Hyun ^a   Ryu, Hee Sug ^c   Min, Churl K ^a  

^a Ajou University   (South Korea)

^b Departments of Anatomy   (South Korea)

^c Ajou University School of Medicine   (South Korea)

Author keywords

Angiogenesis; Endometrial tumor xenograft; Matrix metalloproteinase; Syndecan 1

Indexed keywords

CD34 ANTIGEN; GELATINASE A; GELATINASE B; SYNDECAN 1; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CONTROLLED STUDY; ENDOMETRIUM CANCER; ENZYME ACTIVATION; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS TISSUE TUMOR; TUMOR XENOGRAFT; UPREGULATION; ZYMOGRAPHY;

ADENOCARCINOMA; ANIMALS; CELL LINE, TUMOR; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; SYNDECAN-1; TRANSPLANTATION, HETEROLOGOUS; UP-REGULATION;

EID: 77956827788     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/IGC.0b013e3181e02faa     Document Type: Article

References (25)

1. Amant F, Moerman P, Neven P, et al. Endometrial cancer. Lancet. 2005;366:491Y505.
2. Van Eycken E. Kankerincidentie in Vlaanderen 2000. Available at: Http://www.tegenkanker.net. Accessed June 1, 2005.
3. Smith RA, Cokkinides V, Eyre HJ. American Cancer Society guidelines for the early detection of cancer, 2003. CA Cancer J Clin. 2003;53:27Y43.
4. Zimmermann P, David G. The syndecans, tuners of transmembrane signaling. FASEB J. 1999;13:S91YS100.
5. Bernfield M, Gotte M, Park PW, et al. Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem. 1999;68: 729Y777.
6. Liebersbach BF, Sanderson RD. Expression of syndecan-1 inhibits cell invasion into type I collagen. J Biol Chem. 1994;269:20013Y20019.
7. Shinyo Y, Kodama J, Hasegaowa, et al. Loss of cell-surface heparan sulfate expression in both cervical intraepithelial neoplasm and invasive cervical cancer. Gynecol Oncol. 2005;96:776Y783.
8. Barbareschi M, Maisonneuve P, Aldovini D, et al. High syndecan-1 expression in breast carcinoma is related to an aggressive phenotype and to poorer prognosis. Cancer. 2003;98:474Y483.
9. Davies EJ, Blackhall FH, Shanks JH, et al. Distribution and clinical significance of heparan sulfate proteoglycans in ovarian cancer. Clin Cancer Res. 2004;10:5178Y5186.
10. Choi DS, Kim JH, Ryu HS, et al. Syndecan-1, a key regulator of cell viability in endometrial cancer. Int J Cancer. 2007;121:741Y750.
11. Egelbad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer. 2002;2:161Y174.
12. Noel A, Jost M, Maquoi E. Matrix metalloproteinases at cancer tumor-host interface. Semin Cell Dev Biol. 2008;19:52Y60.
13. Oh JH, Kim JH, Ahn HJ, et al. Syndecan-1 enhances the endometrial cancer invasion by modulating matrix metalloproteinase-9 expression through nuclear factor JB. Gynecol Oncol. 2009;114:509Y515.
14. Hendriksen EM, Span PN, Schuuring J, et al. Angiogenesis, hypoxia and VEGF expression during tumour growth in a human xenograft tumour model. Microvasc Res. 2009;77: 96Y103.
15. Folkman J. The role of angiogenesis in tumor growth. Semin Cancer Biol. 1992;3:65Y71.
16. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med. 1995;1:27Y31.
17. Jungeström MB, Thompson LU, Dabrosin C. Flaxseed and its lignans inhibits estradiol-induced growth, angiogenesis, and secretion of vascular endothelial growth factor in human breast cancer xenografts in vivo. Clin Cancer Res. 2007;13: 1061Y1067.
18. Balbi G, Monteverde A, Passaro M, et al. Vascular endothelial growth factor (VEGF): Can we use it as prognostic factor in endometrial cancer? Minerva Ginecol. 2006;58: 411Y415.
19. Jakobsson L, Kreuger J, Holmborn K, et al. Heparan sulfate in trans potentiates VEGFR-mediated angiogenesis. Dev Cell. 2006;10:625Y634.
20. Hah NS, Lee ST. An absolute role of the PKC-dependent NF-JB activation for induction of MMP-9 in hepatocellular carcinoma cells. Biochem Biophys Res Commun. 2003;305: 428Y433.
21. Duxburya MS, Whang EE. RRM2 induces NF-JBYdependent MMP-9 activation and enhances cellular invasiveness. Biochem Biophys Res Commun. 2007;354:190Y196.
22. Tai KY, Shieh YS, Lee CS, et al. Axl promotes cell invasion by inducing MMP-9 activity through activation of NF-JB and Brg-1. Oncogene. 2008;27:4044Y4055.
23. Kaushal GP, Xiong X, Athota AB, et al. Syndecan-1 expression suppresses the level of myeloma matrix metalloproteinase-9. Br J Haematol. 1999;104:365Y373.
24. Brule S, Charnaux N, Sutton A, et al. The shedding of syndecan-4 and syndecan-1 from HeLa cells and human primary macrophages is accelerated by SDF-1/CXCL12 and mediated by the matrix metalloproteinase-9. Glycobiology. 2006;16:488Y501.
25. Mythreye K, Blobe G. Proteoglycan signaling co-receptors: Roles in cell adhesion, migration and invasion. Cell Signal. 2009;21:1548Y1558.